Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance

Journal of Clinical Investigation

Volumn 116, Issue 4, 2006, Pages 916-928

  Dillon, Stephanie ^a   Agrawal, Sudhanshu ^a   Banerjee, Kaustuv ^a   Letterio, John ^b   Denning, Timothy L ^a   Oswald Richter, Kyra ^c   Kasprowicz, Deborah J ^d   Kellar, Kathryn ^e   Pare, Jeff ^f   Van Dyke, Thomas ^g   Ziegler, Steven ^d   Unutmaz, Derya ^c   Pulendran, Bali ^a,f  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BENAROYA RESEARCH INSTITUTE   (United States)

^e NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^f EMORY UNIVERSITY   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CYTOKINE RELEASE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MACROPHAGE; MALE; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; YEAST;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; SPLEEN; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; YEASTS; ZYMOSAN;

EID: 32944463876     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI27203     Document Type: Article

References (39)

1. Janeway, C.A., Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54:1-13.
2. Shortman, K., and Liu, Y.J. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-161.
3. Pulendran, B. 2004. Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol. Rev. 199:227-250.
4. Pasare, C., and Medzhitov, R. 2004. Toll-like receptors and acquired immunity. Semin. Immunol. 16:23-26.
5. Takeda, K., Kaisho, T., and Akira, S. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
6. van Kooyk, Y., and Geijtenbeek, T.B. 2003. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3:697-709.
7. Cambi, A., and Figdor, C.G. 2003. Dual function of C-type lectin-like receptors in the immune system. Curr. Opin. Cell Biol. 15:539-546.
8. Gordon, S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell. 111:927-930.
9. Toshchakov, V., et al. 2002. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3:392-398.
10. Ito, T., et al. 2002. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J. Exp. Med. 195:1507-1512.
11. Hoebe, K., et al. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature. 424:743-748.
12. Yamamoto, M., et al. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 301:640-643.
13. Agrawal, S., et al. 2003. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen- activated protein kinase and c-Fos. J. Immunol. 171:4984-4989.
14. Dillon, S., et al. 2004. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J. Immunol. 172:4733-4743.
15. Engering, A., Geijtenbeek, T.B., and van Kooyk, Y. 2002. Immune escape through C-type lectins on dendritic cells. Trends Immunol. 23:480-485.
16. Brown, G.D., and Gordon, S. 2001. Immune recognition. A new receptor for beta-glucans. Nature. 413:36-37.
17. Brown, G.D., et al. 2002. Dectin-1 is a major beta-glucan receptor on macrophages. J. Exp. Med. 196:407-412.
18. Reid, D.M., et al. 2004. Expression of the beta-glucan receptor, Dectin-1, on murine leukocytes in situ correlates with its function in pathogen recognition and reveals potential roles in leukocyte interactions. J. Leukoc. Biol. 76:86-94.
19. Yokota, K., Takashima, A., Bergstresser, P.R., and Ariizumi, K. 2001. Identification of a human homologue of the dendritic cell-associated C-type lectin-1, dectin-1. Gene. 272:51-60.
20. Gantner, B.N., Simmons, R.M., Canavera, S.J., Akira, S., and Underhill, D.M. 2003. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197:1107-1117.
21. Manickasingham, S.P., Edwards, A.D., Schulz, O., and Reis e Sousa, C. 2003. The ability of murine dendritic cell subsets to direct T helper cell differentiation is dependent on microbial signals. Eur J. Immunol. 33:101-107.
22. Edwards, A.D., et al. 2002. Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. J. Immunol. 169:3652-3660.
23. Pasare, C., and Medzhitov, R. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 299:1033-1036.
24. Underhill, D.M., et al. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature. 401:811-815.
25. Murray, P.J. 2005. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc. Natl. Acad. Sci. U. S. A. 102:8686-8691.
26. Hawrylowicz, C.M., and O'Garra, A. 2005. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat. Rev. Immunol. 5:271-283.
27. Sanguedolce, M.V., Capo, C., Bongrand, P., and Mege, J.L. 1992. Zymosan-stimulated tumor necrosis factor-alpha production by human monocytes. Down-modulation by phorbol ester. J. Immunol. 148:2229-2236.
28. Kearney, E.R., Pape, K.A., Loh, D.Y., and Jenkins, M.K. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity. 1:327-339.
29. Underhill, D.M., Rossnagle, E., Lowell, C.A., and Simmons, R.M. 2005. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood. 106:2543-2550.
30. Brown, G.D., and Gordon, S. 2003. Fungal beta-glucans and mammalian immunity. Immunity. 19:311-315.
31. Keystone, E.C., Schorlemmer, H.U., Pope, C., and Allison, A.C. 1977. Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum. 20:1396-1401.
32. Yoshitomi, H., et al. 2005. A role for fungal beta-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J. Exp. Med. 201:949-960.
33. Rogers, N.C., et al. 2005. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity. 22:507-517.
34. Sedlik, C., et al. 2003. A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation. J. Immunol. 170:846-852.
35. Romani, L. 2004. Immunity to fungal infections. Nat. Rev. Immunol. 4:1-23.
36. Bozza, S., et al. 2004. Dendritic cell-based vaccination against opportunistic fungi. Vaccine. 22:857-864.
37. Selcher, J.C., Nekrasova, T., Paylor, R., Landreth, G.E., and Sweatt, J.D. 2001. Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning. Learn. Mem. 8:11-19.
38. Barnden, M.J., Allison, J., Heath, W.R., and Carbone, F.R. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76:34-40.
39. Lapointe, R., Toso, J.F., Butts, C., Young, H.A., and Hwu, P. 2000. Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes. Eur J. Immunol. 30:3291-3298.